Choosing the first biologic in pediatric Crohn's disease: Evidence, uncertainty, and the continuing role of anti-TNF therapy. // Best Practice & Research Clinical Gastroenterology. – URL: https://www.sciencedirect.com/science/article/pii/S1521691826000739?dgcid=rss_sd_all
Choosing the first biologic in pediatric Crohn's disease: Evidence, uncertainty, and the continuing role of anti-TNF therapy. Best Practice & Research Clinical Gastroenterology. https://www.sciencedirect.com/science/article/pii/S1521691826000739?dgcid=rss_sd_all
“Choosing the first biologic in pediatric Crohn's disease: Evidence, uncertainty, and the continuing role of anti-TNF therapy.” Best Practice & Research Clinical Gastroenterology.
@article{article37394,
title = {Choosing the first biologic in pediatric Crohn's disease: Evidence, uncertainty, and the continuing role of anti-TNF therapy},
journal = {Best Practice \& Research Clinical Gastroenterology},
url = {https://www.sciencedirect.com/science/article/pii/S1521691826000739?dgcid=rss_sd_all}
}